ABALLI JOHN 4
4 · EXAGEN INC. · Filed Oct 18, 2023
Insider Transaction Report
Form 4
EXAGEN INC.XGN
ABALLI JOHN
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2023-10-17$1.75/sh−33,819$59,018→ 415,984 total
Footnotes (1)
- [F1]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on October 16, 2022.